Search results for abx831314
Showing 1 – 10 of1products
ID: BAB671772322
Vanucizumab, Abbexa, abx831314
Vanucizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ANGPT2/VEGFA, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Vanucizumab has been used in trials studying the treatment of ColoRectal Cancer and Advanced/Metastatic Solid Tumors.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Request a product
Please provide the required information below so that we can quickly source your products.